Current nonsurgical treatment options and concepts for soft tissue sarcoma in adults

被引：0

作者：

Hofmann, G. ^{[1
]}

Ploner, F. ^{[1
]}

Liegl-Atzwanger, B. ^{[2
]}

Langsenlehner, T. ^{[3
]}

机构：

[1] Med Univ Graz, Div Oncol, Dept Internal Med, A-8036 Graz, Austria

[2] Med Univ Graz, Inst Pathol, A-8036 Graz, Austria

[3] Med Univ Graz, Dept Therapeut Radiol & Oncol, A-8036 Graz, Austria

来源：

EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA | 2009年 / 41卷 / 04期

关键词：

Soft tissue sarcoma; chemotherapy; radiotherapy; adjuvant; ISOLATED LIMB PERFUSION; TUMOR-NECROSIS-FACTOR; RANDOMIZED PHASE-II; RADIATION-THERAPY; EUROPEAN-ORGANIZATION; PROGNOSTIC-FACTORS; POSTOPERATIVE RADIOTHERAPY; COMBINATION CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; LIPOSOMAL DOXORUBICIN;

D O I：

10.1007/s10353-009-0480-y

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

BACKGROUND: Soft tissue sarcomas (STS) are a rare group of tumors with mesenchymal origin. They account for about 1% of all malignancies in adults. Due to the rareness of this tumor group, randomized clinical trials are scarce and there is little evidence concerning treatment options. METHODS: Clinical trials, published to date and literature were reviewed and edited. RESULTS: Possible different treatment approaches reflecting the present standard of care are presented and discussed. CONCLUSIONS: A multidisciplinary therapy approach and more randomized clinical trials are mandatory to improve the care for patients with STS.

引用

页码：170 / 175

页数：6

共 63 条

[1] Malignant peripheral nerve sheath tumors - Prognostic factors and survival in a series of patients treated at a single institution [J].

Anghileri, Matteo ;

Miceli, Rosalba ;

Fiore, Marco ;

Mariani, Luigi ;

Ferrari, Andrea ;

Mussi, Chiara ;

Lozza, Laura ;

Collini, Paola ;

Olmi, Patrizia ;

Casali, Paolo G. ;

Pilotti, Silvana ;

Gronchi, Alessandro .

CANCER, 2006, 107 (05) :1065-1074

[2]

[Anonymous], 2008, J CLIN ONCOL

[3] Targeting angiogenesis for the treatment of sarcoma [J].

Balasubramanian, Lakshmi ;

Evens, Andrew M. .

CURRENT OPINION IN ONCOLOGY, 2006, 18 (04) :354-359

[4] Sorafenib is active on lung metastases from synovial sarcoma [J].

Basso, U. ;

Brunello, A. ;

Bertuzzi, A. ;

Santoro, A. .

ANNALS OF ONCOLOGY, 2009, 20 (02) :386-387

[5]

Cassier Philippe A, 2008, Ther Clin Risk Manag, V4, P109

[6]

Coindre JM, 2001, CANCER-AM CANCER SOC, V91, P1914, DOI 10.1002/1097-0142(20010515)91:10<1914::AID-CNCR1214>3.0.CO

[7]

2-3

[8] Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma [J].

Davis, AM ;

O'Sullivan, B ;

Turcotte, R ;

Bell, R ;

Catton, C ;

Chabot, P ;

Wunder, J ;

Hammond, A ;

Benk, V ;

Kandel, R ;

Goddard, K ;

Zee, B ;

Day, A ;

Tu, DS ;

Pater, J .

RADIOTHERAPY AND ONCOLOGY, 2005, 75 (01) :48-53

[9] High-grade extremity soft tissue sarcomas - Factors predictive of local recurrence and its effect on morbidity and mortality [J].

Eilber, FC ;

Rosen, G ;

Nelson, SD ;

Selch, M ;

Dorey, F ;

Eckardt, J ;

Eilber, FR .

ANNALS OF SURGERY, 2003, 237 (02) :218-226

[10] Treatment-induced pathologic necrosis: A predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas [J].

Eilber, FC ;

Rosen, G ;

Eckardt, J ;

Forscher, C ;

Nelson, SD ;

Selch, M ;

Dorey, F ;

Eilber, FR .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (13) :3203-3209

← 1 2 3 4 5 6 7 →